RESUMO
BACKGROUND: Kwasaki disease (KD) is the leading cause of acquired heart disease in children in most developed countries. The cause of KD remains unknown. The presumed theory is that KD occurs due to one or more infectious agents who evoke an abnormal immunological response in susceptible individuals. Epstein - Barr virus (EBV) infection has been considered as a suspected causative agent because of the potential effect on the immune system. CASE PRESENTATION: A previously healthy 19 month old boy presented with a 6 day history of fever accompanied by a diffuse macular erythematous rash that appeared 1 day after. The physical examination on admission revealed bilateral non-suppurative conjunctivitis, dry fissured and injected lips without "strawberry" tongue, diffuse macular rash on the trunk, face and limbs, swelling of the hands and feet, and right cervical lymphadenopathy (2 cm in diameter). Following fulfillment of all the clinical criteria, the diagnosis of KD was made and treatment with IVIG 2 g/Kg was administered along with oral aspirin (80 mg/ kg/day). However, despite the treatment, he remained febrile for an additional 2 days with persistent clinical manifestations. Therefore, he received a second 2 g/kg IVIG course with a favorable response. On the 14th day of illness the patient became febrile again and was readmitted. Blood examinations revealed remarkable leukocytosis up to 35.7 X 109/L with 87.3% lymphocytes and the blood smear revealed atypical lymphocytes and monocytes. The liver enzymes were elevated. The serology for infectious mononucleosis from his first admission revealed: IgM CMV (+), IgG CMV (-); IgM VCA EBV (+) IgG VCA EBV (-), IgG EBNA (-). To confirm infectious mononucleosis following the administration of 2 doses of IVIG, serum EBV PCR was performed and was positive (1.6X 103 cp/ml). CONCLUSIONS: We describe here a case of KD with a concomitant primary EBV infection. To the best of our knowledge, this is the first case in western country that describes KD with acute EBV infection as confirmed by PCR. The case we described stands as a contribution in favor of the possible role of EBV in the development of KD.
Assuntos
Aspirina/administração & dosagem , DNA Viral/isolamento & purificação , Infecções por Vírus Epstein-Barr , Herpesvirus Humano 4/isolamento & purificação , Imunoglobulinas Intravenosas/administração & dosagem , Mononucleose Infecciosa , Síndrome de Linfonodos Mucocutâneos , Anti-Inflamatórios não Esteroides/administração & dosagem , Infecções por Vírus Epstein-Barr/sangue , Infecções por Vírus Epstein-Barr/complicações , Infecções por Vírus Epstein-Barr/fisiopatologia , Infecções por Vírus Epstein-Barr/terapia , Humanos , Fatores Imunológicos/administração & dosagem , Lactente , Mononucleose Infecciosa/sangue , Mononucleose Infecciosa/complicações , Mononucleose Infecciosa/fisiopatologia , Mononucleose Infecciosa/terapia , Masculino , Síndrome de Linfonodos Mucocutâneos/complicações , Síndrome de Linfonodos Mucocutâneos/diagnóstico , Síndrome de Linfonodos Mucocutâneos/fisiopatologia , Síndrome de Linfonodos Mucocutâneos/terapia , Testes Sorológicos/métodos , Resultado do TratamentoRESUMO
BACKGROUND: Infectious mononucleosis (IM) is a common disease of adolescents and young adults, characterized by a specific triad of symptoms represented by fever, sore throat and lymphadenopathy. IM may also affect older adults, with different, more intense signs and symptoms such as fatigue, general malaise, and diffuse body pain. The aim of this four-week-registry study was to evaluate the effects of Robuvit® supplementation on the main consequences of mononucleosis, particularly fatigue, in otherwise healthy adults. METHODS: All patients enrolled in this registry study experienced an episode of IM characterized by fatigue, a general feeling of unwellness, diffuse body and muscular pain, leukocytosis, and high levels of oxidative stress, at least 2 to 4 weeks prior to inclusion. Fever had already resolved at inclusion. All included patients were positively tested for the Epstein-Barr virus (EBV). Subjects were divided in two groups: those receiving the standard management (SM, N.=26; vitamin B, C, and D, balanced healthy diet, regular sleeping schedule, physical activity, 2 mg copper), and those treated with SM plus Robuvit® (N.=24) supplementation (300 mg/day). RESULTS: Supplementation with Robuvit® was safe, overall tolerability was good, and no side effects were reported. All patients completed the four-week treatment. After 4 weeks of treatment, a significant reduction in the rate of symptoms was evident in the Robuvit® group compared to the control group (P<0.05). CONCLUSIONS: Supplementation with Robuvit® is safe, well tolerated, and effective in controlling oxidative stress levels and improving fatigue and other symptoms related to IM episodes during the convalescence period.
Assuntos
Suplementos Nutricionais , Fadiga/terapia , Taninos Hidrolisáveis/administração & dosagem , Mononucleose Infecciosa/terapia , Extratos Vegetais/administração & dosagem , Adulto , Fadiga/etiologia , Feminino , Humanos , Mononucleose Infecciosa/fisiopatologia , Masculino , Estresse Oxidativo , Sistema de Registros , Resultado do TratamentoRESUMO
OBJECTIVE: To determine appropriate management of the active individual with infectious mononucleosis (IM), including issues of diagnosis, the determination of splenomegaly, and other measures of disease status, the relationship of the disease to chronic fatigue syndrome (CFS), and the risks of exercise at various points in the disease process. DATA SOURCES: An Ovid/MEDLINE search (January 1996-June 2015) was widely supplemented by "similar articles" found in Ovid/MEDLINE and PubMed, reference lists, and personal files. MAIN RESULTS: Clinical diagnoses of IM are unreliable. Traditional laboratory indicators (lymphocytosis, abnormal lymphocytes, and a heterophile-positive slide test) can be supplemented by more sensitive and more specific but also more costly Epstein-Barr antigen determinations. Clinical estimates of splenomegaly are fallible. Laboratory determinations, commonly by 2D ultrasonography, must take account of methodology, the formulae used in calculations and the individual's body size. The SD of normal values matches the typical increase of size in IM, but repeat measurements can help to monitor regression of the disease. The main risks to the athlete are spontaneous splenic rupture (seen in 0.1%-0.5% of patients and signaled by acute abdominal pain) and progression to chronic fatigue, best avoided by 3 to 4 weeks of restricted activity followed by graded reconditioning. A full recovery of athletic performance is usual with 2 to 3 months of conservative management. CONCLUSIONS: Infectious mononucleosis is a common issue for young athletes. But given accurate diagnosis and the avoidance of splenic rupture and progression to CFS through a few weeks of restricted activity, long-term risks to the health of athletes are few.
Assuntos
Exercício Físico , Síndrome de Fadiga Crônica/etiologia , Mononucleose Infecciosa/complicações , Esplenomegalia/etiologia , Atletas , Humanos , Mononucleose Infecciosa/diagnóstico , Mononucleose Infecciosa/fisiopatologia , Esplenomegalia/diagnóstico por imagemRESUMO
Acute infectious mononucleosis (AIM) is a widespread viral disease that mostly affects children. Development of AIM is accompanied by a change in the ratio of immune cells. This is provided by means of different biological processes including the regulation of apoptosis of naive T-cells. One of the potential regulators of apoptosis of T-lymphocytes is a death receptor 3 (DR3). We have studied the role of DR3 in the regulation of apoptosis of naive CD4+ (nTh) and CD8+ (nCTL) T-cells in healthy children and children with AIM. In healthy children as well as in children with AIM, the activation of DR3 is accompanied by inhibition of apoptosis of nTh. In healthy children, the stimulation of DR3 resulted in the increase in apoptosis of nCTL. On the contrary, in children with AIM, the level of apoptosis of nCTL decreased after DR3 activation, which is a positive contribution to the antiviral immune response. In children with AIM, nCTL are characterized by reduced level of apoptosis as compared with healthy children. These results indicate that DR3 can be involved in the reduction of sensitivity of nCTL to apoptosis in children with AIM.
Assuntos
Apoptose , Mononucleose Infecciosa/metabolismo , Membro 25 de Receptores de Fatores de Necrose Tumoral/metabolismo , Linfócitos T/citologia , Adolescente , Criança , Feminino , Humanos , Mononucleose Infecciosa/genética , Mononucleose Infecciosa/fisiopatologia , Masculino , Membro 25 de Receptores de Fatores de Necrose Tumoral/genética , Linfócitos T/metabolismoRESUMO
The article highlights the clinical features of infectious mononucleosis in children (based on the analysis of the data for children of different ages treated in Odessa clinical hospital of infectious diseases in connection with infectious mononucleosis) based on etiological factors.
Assuntos
Infecções por Citomegalovirus/fisiopatologia , Infecções por Vírus Epstein-Barr/fisiopatologia , Mononucleose Infecciosa/fisiopatologia , Infecções por Roseolovirus/fisiopatologia , Criança , Pré-Escolar , Citomegalovirus/patogenicidade , Citomegalovirus/fisiologia , Infecções por Citomegalovirus/diagnóstico , Infecções por Citomegalovirus/virologia , Infecções por Vírus Epstein-Barr/diagnóstico , Infecções por Vírus Epstein-Barr/virologia , Feminino , Herpesvirus Humano 4/patogenicidade , Herpesvirus Humano 4/fisiologia , Herpesvirus Humano 6/patogenicidade , Herpesvirus Humano 6/fisiologia , Humanos , Lactente , Mononucleose Infecciosa/diagnóstico , Mononucleose Infecciosa/virologia , Masculino , Infecções por Roseolovirus/diagnóstico , Infecções por Roseolovirus/virologia , Fatores SexuaisRESUMO
Epstein-Barr is a ubiquitous virus that infects 95% of the world population at some point in life. Although Epstein-Barr virus (EBV) infections are often asymptomatic, some patients present with the clinical syndrome of infectious mononucleosis (IM). The syndrome most commonly occurs between 15 and 24 years of age. It should be suspected in patients presenting with sore throat, fever, tonsillar enlargement, fatigue, lymphadenopathy, pharyngeal inflammation, and palatal petechiae. A heterophile antibody test is the best initial test for diagnosis of EBV infection, with 71% to 90% accuracy for diagnosing IM. However, the test has a 25% false-negative rate in the first week of illness. IM is unlikely if the lymphocyte count is less than 4,000 mm3. The presence of EBV-specific immunoglobulin M antibodies confirms infection, but the test is more costly and results take longer than the heterophile antibody test. Symptomatic relief is the mainstay of treatment. Glucocorticoids and antivirals do not reduce the length or severity of illness. Splenic rupture is an uncommon complication of IM. Because physical activity within the first three weeks of illness may increase the risk of splenic rupture, athletic participation is not recommended during this time. Children are at the highest risk of airway obstruction, which is the most common cause of hospitalization from IM. Patients with immunosuppression are more likely to have fulminant EBV infection.
Assuntos
Obstrução das Vias Respiratórias , Gerenciamento Clínico , Herpesvirus Humano 4/imunologia , Mononucleose Infecciosa , Ruptura Esplênica , Adolescente , Obstrução das Vias Respiratórias/etiologia , Obstrução das Vias Respiratórias/prevenção & controle , Anticorpos Antivirais/análise , Humanos , Imunoglobulina M/análise , Mononucleose Infecciosa/complicações , Mononucleose Infecciosa/diagnóstico , Mononucleose Infecciosa/fisiopatologia , Mononucleose Infecciosa/terapia , Mononucleose Infecciosa/virologia , Testes Sorológicos/métodos , Ruptura Esplênica/etiologia , Ruptura Esplênica/prevenção & controle , Adulto JovemRESUMO
Infection by the Epstein-Barr virus (EBV) has been linked to the development of autoimmune diseases and recent studies have investigated its specific influence on inflammatory bowel diseases. This is a case report of a 20 year old patient who was diagnosed with Crohn's disease following a prolonged manifestation of infectious mononucleosis. The current information regarding the association between EBV and the development of inflammatory bowel diseases is discussed.
Assuntos
Anticorpos Monoclonais/administração & dosagem , Doença de Crohn , Herpesvirus Humano 4/isolamento & purificação , Mononucleose Infecciosa , Antirreumáticos/administração & dosagem , Doença de Crohn/diagnóstico , Doença de Crohn/tratamento farmacológico , Doença de Crohn/etiologia , Doença de Crohn/fisiopatologia , Trato Gastrointestinal/imunologia , Humanos , Mononucleose Infecciosa/complicações , Mononucleose Infecciosa/diagnóstico , Mononucleose Infecciosa/fisiopatologia , Mononucleose Infecciosa/virologia , Infliximab , Masculino , Monitorização Imunológica/métodos , Resultado do Tratamento , Adulto JovemAssuntos
Infecções por HIV/diagnóstico , Hepatite Viral Humana/diagnóstico , Mononucleose Infecciosa/diagnóstico , Meningoencefalite/diagnóstico , Diagnóstico Diferencial , Infecções por HIV/fisiopatologia , Hepatite Viral Humana/fisiopatologia , Humanos , Mononucleose Infecciosa/fisiopatologia , Meningoencefalite/fisiopatologiaRESUMO
BACKGROUND: Infectious mononucleosis (IM) or Mononucleosis syndrome is caused by an acute infection of Epstein-Barr virus. In Latin American countries, there are little information pertaining to the clinical manifestations and complications of this disease. For this reason, the purpose of this work was to describe the clinical and laboratory characteristics of infection by Epstein-Barr virus in Mexican children with infectious mononucleosis. METHODS: A descriptive study was carried out by reviewing the clinical files of patients less than 18 years old with clinical and serological diagnosis of IM by Epstein-Barr virus from November, 1970 to July, 2011 in a third level pediatric hospital in Mexico City. RESULTS: One hundred and sixty three cases of IM were found. The most frequent clinical signs were lymphadenopathy (89.5%), fever (79.7%), general body pain (69.3%), pharyngitis (55.2%), hepatomegaly (47.2%). The laboratory findings were lymphocytosis (41.7%), atypic lymphocytes (24.5%), and increased transaminases (30.9%), there were no rupture of the spleen and no deaths among the 163 cases. CONCLUSIONS: Our results revealed that IM appeared in earlier ages compared with that reported in industrialized countries, where adolescents are the most affected group. Also, the order and frequency of the clinical manifestations were different in our country than in industrialized ones.
Assuntos
Infecções por Vírus Epstein-Barr/sangue , Infecções por Vírus Epstein-Barr/patologia , Herpesvirus Humano 4/fisiologia , Mononucleose Infecciosa/sangue , Mononucleose Infecciosa/patologia , Adolescente , Distribuição por Idade , Criança , Pré-Escolar , Infecções por Vírus Epstein-Barr/fisiopatologia , Infecções por Vírus Epstein-Barr/virologia , Testes Hematológicos , Humanos , Lactente , Recém-Nascido , Mononucleose Infecciosa/fisiopatologia , Mononucleose Infecciosa/virologia , Fígado/patologia , Fígado/fisiopatologia , Fígado/virologia , Testes de Função Hepática , Linfócitos/patologia , MéxicoRESUMO
Multiple sclerosis (MS) is a heterogeneous disease that develops as an interplay between the immune system and environmental stimuli in genetically susceptible individuals. There is increasing evidence that viruses may play a role in MS pathogenesis acting as these environmental triggers. However, it is not known if any single virus is causal, or rather several viruses can act as triggers in disease development. Here, we review the association of different viruses to MS with an emphasis on two herpesviruses, Epstein-Barr virus (EBV) and human herpesvirus 6 (HHV-6). These two agents have generated the most impact during recent years as possible co-factors in MS disease development. The strongest argument for association of EBV with MS comes from the link between symptomatic infectious mononucleosis and MS and from seroepidemiological studies. In contrast to EBV, HHV-6 has been found significantly more often in MS plaques than in MS normal appearing white matter or non-MS brains and HHV-6 re-activation has been reported during MS clinical relapses. In this review we also suggest new strategies, including the development of new infectious animal models of MS and antiviral MS clinical trials, to elucidate roles of different viruses in the pathogenesis of this disease. Furthermore, we introduce the idea of using unbiased sequence-independent pathogen discovery methodologies, such as next generation sequencing, to study MS brain tissue or body fluids for detection of known viral sequences or potential novel viral agents.
Assuntos
Infecções por Vírus Epstein-Barr/fisiopatologia , Herpesvirus Humano 4/fisiologia , Herpesvirus Humano 6/patogenicidade , Esclerose Múltipla/virologia , Infecções por Roseolovirus/fisiopatologia , Animais , Antivirais/uso terapêutico , Autoimunidade , Modelos Animais de Doenças , Infecções por Vírus Epstein-Barr/tratamento farmacológico , Infecções por Vírus Epstein-Barr/virologia , Herpesvirus Humano 4/efeitos dos fármacos , Herpesvirus Humano 4/patogenicidade , Herpesvirus Humano 6/efeitos dos fármacos , Herpesvirus Humano 6/imunologia , Herpesvirus Humano 6/fisiologia , Humanos , Mononucleose Infecciosa/imunologia , Mononucleose Infecciosa/fisiopatologia , Mononucleose Infecciosa/virologia , Mimetismo Molecular , Esclerose Múltipla/etiologia , Esclerose Múltipla/imunologia , Esclerose Múltipla/prevenção & controle , Fatores de Risco , Infecções por Roseolovirus/tratamento farmacológico , Infecções por Roseolovirus/virologia , Prevenção Secundária , Ativação Viral/efeitos dos fármacosRESUMO
This report describes the case of a previously healthy young man who presented with fever, pharyngitis, cervical lymphadenopathy, lymphocytosis, and severe thrombocytopenia. Serological tests for Epstein-Barr virus were diagnostic of a primary Epstein-Barr virus infectious mononucleosis but severe thrombocytopenia aroused the suspicion of a lymphoproliferative disease. T-cell receptor gene analysis performed on peripheral and bone marrow blood revealed a T-cell receptor γ-chain rearrangement without the evidence of malignancy using standard histologic and immunophenotype studies. Signs and symptoms of the infectious disease, blood count, and T-cell receptor gene rearrangement resolved with observation without the evidence of emergence of a lymphoproliferative disease. In the contest of a suspected lymphoproliferative disease, molecular results should be integrated with all available data for an appropriate diagnosis.
Assuntos
Rearranjo Gênico , Genes Codificadores da Cadeia gama de Receptores de Linfócitos T/genética , Mononucleose Infecciosa/genética , Mononucleose Infecciosa/fisiopatologia , Humanos , Mononucleose Infecciosa/patologia , Masculino , Adulto JovemRESUMO
Clinical options of infectious mononucleosis course depending on infecting agent etiology are presented for Epstein-Barr virus (EBV), cytomegalovirus (CMV), mono and mixed forms of the disease. Examined cytokine profiles demonstrate analogous changes of serum cytokines in the acute stage of the disease irrespective of etiological factors. Data show that it is important and useful clinically and immunologically to include immunomodulators--in particular, cycloferon--info a complex therapy of different types of mononucleosis.
Assuntos
Acridinas/uso terapêutico , Citocinas/sangue , Fatores Imunológicos/uso terapêutico , Imunoterapia/métodos , Mononucleose Infecciosa/tratamento farmacológico , Equilíbrio Th1-Th2/efeitos dos fármacos , Acridinas/administração & dosagem , Administração Oral , Antivirais/administração & dosagem , Estudos de Casos e Controles , Criança , Pré-Escolar , Coinfecção , Citocinas/imunologia , Citomegalovirus/efeitos dos fármacos , Citomegalovirus/imunologia , Feminino , Herpesvirus Humano 4/efeitos dos fármacos , Herpesvirus Humano 4/imunologia , Humanos , Fatores Imunológicos/administração & dosagem , Mononucleose Infecciosa/sangue , Mononucleose Infecciosa/imunologia , Mononucleose Infecciosa/fisiopatologia , Mononucleose Infecciosa/virologia , Masculino , Federação RussaRESUMO
A 20-year-old woman presented with a 2-week history of fever and malaise. Physical examination was unremarkable. Viral infection was suspected and Epstein-Barr virus serology confirmed acute infectious mononucleosis. During admission, she gradually developed pancytopenia and liver enzyme abnormalities. The patient clinically deteriorated with persisting fever, orthostatic hypotension and hepatosplenomegaly. Bone marrow examination showed haemophagocytic lymphohistiocytosis (HLH). Treatment with high-dose corticosteroids was started and patient recovered quickly. Ferritin decreased immediately, fever resolved within 3 days, viral clearance was reached within 3 weeks. Steroid therapy was gradually tapered off in three months. The Histiocyte Society recommends immunochemotherapy with steroids, etoposide and cyclosporine. Potential side effects of etoposide are severe bone marrow depression and leukaemia. Our patient survived on corticosteroids alone. Early recognition of HLH and prompt treatment are of utmost importance for survival. Treatment with steroids alone can be life-saving.
Assuntos
Corticosteroides/uso terapêutico , Mononucleose Infecciosa/tratamento farmacológico , Linfo-Histiocitose Hemofagocítica/tratamento farmacológico , Corticosteroides/administração & dosagem , Adulto , Feminino , Ferritinas/sangue , Humanos , Mononucleose Infecciosa/complicações , Mononucleose Infecciosa/fisiopatologia , Fígado/fisiopatologia , Linfo-Histiocitose Hemofagocítica/virologia , Pancitopenia/virologia , Fatores de Tempo , Adulto JovemRESUMO
Upper respiratory tract infections are frequent in athletes. Mainly of viral origin, they are treated symptomatically. Infectious mononucleosis is associated with an estimated 2% per hundred risk of splenic rupture, which occurs between day four and twenty one of the illness. Therefore return to play guidelines recommend avoiding, exercice during the first twenty one days. Physical exercise seems to influence the immune system, depending on the intensity and length of it. But the relationship between physical exercise and risk of infections remains controversial: some articles showing an increase in risk, whereas others suggesting a certain degree of protection, in athletes. The actual generally accepted working theory is the J-curve proposed by Nieman. This model remains to be formally proven.
Assuntos
Infecções Respiratórias/imunologia , Infecções Respiratórias/fisiopatologia , Esportes/fisiologia , Imunidade Adaptativa , Humanos , Imunidade Inata , Mononucleose Infecciosa/imunologia , Mononucleose Infecciosa/fisiopatologiaRESUMO
The aim of this study was to analyze the demographic, clinical and laboratory characteristics and prognoses of children diagnosed with infectious mononucleosis (IM). The demographic features, referral complaints, clinical and laboratory findings, follow-up, and prognoses of 44 patients diagnosed with IM between January 2000 and June 2006 at the Infectious Diseases Department of Hacettepe University Ihsan Dogramaci Children's Hospital were analyzed retrospectively. The children suspected of IM based on clinical findings and whose diagnoses were proven by serological tests were enrolled in the study. In addition, the patients were divided into four groups -namely, age 0-4, age 5-8, age 9-12 and age 13-16, and the differences among groups were investigated in terms of their clinical and laboratory findings. The patients were aged between 3 months and 16 years. The median age was 4, and 56.8% of patients were below age 5. The male/female ratio was 1.6. No statistically significant variation was observed in the seasonal distribution of patients (p = 0.131). The most common referral complaints were swollen cervical lymph nodes or swollen neck (68.1%), followed by fever (43.1%) and sore throat (25%). Lymphadenopathy (79.5%), tonsillopharyngitis (72.7%), splenomegaly (34%), and hepatomegaly (25%) were the most common physical examination findings. Leukocyte count was normal in 68.3% of the cases. Leukocytosis was detected in 29.5% of the patients, and leukopenia in 2.2%. Lymphocytosis was detected in 44.7% of patients. Downey cell was detected in the peripheral blood smear of 23.6% of patients, and thrombocytopenia in 11.3%. Elevated alanine aminotransferase and aspartate aminotransferase levels were detected in 61.9% and 90.4% of patients who were investigated for these parameters, respectively. The clinical, hematological and biochemical findings of patients did not vary significantly among age groups (p > 0.05). Only one complication (hemophagocytic syndrome) was observed in one patient.
Assuntos
Mononucleose Infecciosa/diagnóstico , Adolescente , Alanina Transaminase/sangue , Aspartato Aminotransferases/sangue , Sedimentação Sanguínea , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Mononucleose Infecciosa/sangue , Mononucleose Infecciosa/fisiopatologia , Contagem de Leucócitos , Testes de Função Hepática , MasculinoRESUMO
The lack of functional SAP protein, a consequence of mutation or deletion of the SH2D1A gene is the cause of X-linked lymphoproliferative disease (XLP). Others and we have shown that SAP can be involved in apoptosis. Activation induced apoptosis plays a pivotal role in the termination of the lymphocyte proliferation in infectious mononucleosis IM. This mechanism is inefficient in the XLP patients. Primary EBV infection of boys with XLP leads therefore to fulminant, often even fatal disease. In addition, the condition predisposes to considerably elevated incidence of lymphomas. Chromosomal translocation that juxtaposes one of the three immunoglobulin loci to the c-myc proto-oncogene is the hallmark of Burkitt lymphomas (BL), whether they carry the Epstein-Barr Virus (EBV) or not. Ig/myc translocations occur as rare accidents of normal B lymphocyte differentiation. The activated myc would drive the cells to proliferate, however unless protected, the cells become prone to apoptosis. Our results with BL derived cell lines suggest that the fate of the precursor cells is decided by the expression of the proapototic SAP and EBV infection. We found SAP expression in eight of ten EBV carrying, but none of nine EBV negative BL lines. Therefore it seems that the apoptosis prone Ig/myc translocation carrying EBV negative precursors of BL can grow into lymphomas only if they do not express the proapoptotic SAP while SAP expressor, but EBV positive cells can survive and proliferate. This is probably due to the antiapoptotic function of EBNA-1 and the proliferation induced by activated myc.
Assuntos
Linfoma de Burkitt/etiologia , Herpesvirus Humano 4 , Mononucleose Infecciosa/etiologia , Peptídeos e Proteínas de Sinalização Intracelular/genética , Transtornos Linfoproliferativos/imunologia , Animais , Apoptose , Linfoma de Burkitt/fisiopatologia , Deleção de Genes , Humanos , Mononucleose Infecciosa/imunologia , Mononucleose Infecciosa/fisiopatologia , Masculino , Proto-Oncogene Mas , Proteína Associada à Molécula de Sinalização da Ativação LinfocitáriaAssuntos
Antígenos Nucleares do Vírus Epstein-Barr/imunologia , Herpesvirus Humano 4/imunologia , Mononucleose Infecciosa/complicações , Mononucleose Infecciosa/imunologia , Esclerose Múltipla/imunologia , Esclerose Múltipla/virologia , Linfócitos B/imunologia , Biomarcadores/análise , Biomarcadores/sangue , Causalidade , Progressão da Doença , Sistema Imunitário/fisiopatologia , Imunoglobulina G/análise , Imunoglobulina G/sangue , Mononucleose Infecciosa/fisiopatologia , Mimetismo Molecular/imunologia , Esclerose Múltipla/fisiopatologia , Fenótipo , Linfócitos T/imunologia , Regulação para Cima/imunologiaRESUMO
BACKGROUND: Functional polymorphisms in immune response genes are increasingly recognized as important contributors to the marked individual differences in susceptibility to and outcomes of infectious disease. The acute sickness response is a stereotypical set of illness manifestations mediated by the proinflammatory cytokines induced by many different pathogens. The genetic determinants of severity of the acute sickness response have not previously been explored. METHODS: We examined the impact of functional polymorphisms in cytokine genes with critical roles in the early immune response (tumor necrosis factor-alpha, interleukin-6, interleukin-10, and interferon-gamma) on the severity and duration of illness following acute infection with Epstein-Barr virus, Coxiella burnetii (the causative agent of Q fever), or Ross River virus. RESULTS: We found that the interferon-gamma +874T/A and the interleukin-10 -592C/A polymorphisms significantly affected illness severity, cytokine protein levels, and the duration of illness. These cytokine genotypes acted in synergy to potentiate their influence on disease outcomes. CONCLUSIONS: These findings suggest that genetically determined variations in the intensity of the inflammatory response underpin the severity of the acute sickness response and predict the recovery time across varied infections.
Assuntos
Infecções por Alphavirus/imunologia , Citocinas/genética , Citocinas/imunologia , Mononucleose Infecciosa/imunologia , Polimorfismo Genético , Febre Q/imunologia , Adolescente , Adulto , Idoso , Infecções por Alphavirus/patologia , Infecções por Alphavirus/fisiopatologia , Sequência de Bases , Coxiella burnetii/imunologia , Suscetibilidade a Doenças , Feminino , Herpesvirus Humano 4/imunologia , Humanos , Mononucleose Infecciosa/patologia , Mononucleose Infecciosa/fisiopatologia , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Febre Q/patologia , Febre Q/fisiopatologia , Ross River virus/imunologiaRESUMO
A 37-year-old man was presented with incidental findings of neutropenia, atypical lymphocytosis, thrombocytopenia and deranged liver parenchymal enzymes. Four days later, he developed fever, sore throat and cervical lymphadenopathy, compatible with mononucleosis-like illness (MLI). Polymerase chain reaction (PCR) and viral culture of the nasopharyngeal swab showed human metapneumovirus (hMPV). There was a >/=4-fold rise in IgG against hMPV. This is the first case report illustrating the natural clinical course of hMPV-related MLI.
Assuntos
Imunocompetência , Mononucleose Infecciosa , Metapneumovirus/patogenicidade , Infecções por Paramyxoviridae , Adulto , Humanos , Mononucleose Infecciosa/fisiopatologia , Mononucleose Infecciosa/virologia , Masculino , Infecções por Paramyxoviridae/fisiopatologia , Infecções por Paramyxoviridae/virologiaRESUMO
BACKGROUND: Chronic active Epstein-Barr virus (EBV) infection is characterized by recurrent infectious mononucleosis-like symptoms, and infected patients have high viral loads in their peripheral blood. Standard therapy for the disease has not yet been established. Recently, hematopoietic stem cell transplantation (HSCT) has been introduced and has the potential to become a standard treatment, although guidelines for HSCT to treat chronic active EBV infection have not yet been proposed. METHODS: Fifteen patients were retrospectively analyzed, both clinically and virologically, to investigate the factors associated with prognosis of chronic active EBV infection treated with HSCT. RESULTS: After HSCT, 7 patients died after survival periods that ranged from 1 to 16 months (mean duration of survival after HSCT, 5 months). Three patients were considered to have died of transplantation-related complications. The duration between infection onset and diagnosis was significantly longer in patients who died than in those who survived. Five of the 7 patients who died experienced > or =3 life-threatening complications. The plasma concentrations of interferon-gamma, interleukin-10, thrombomodulin, and soluble E-selectin did not differ significantly between the groups of patients. With regard to sequence variations in the EBV latent membrane protein 1 gene, no specific patterns were found in the patients who died. Importantly, the plasma EBV load at diagnosis was significantly higher in patients who died than in living patients. Moreover, plasma viral load was shown to be an important factor to monitor during follow-up for patients after HSCT. CONCLUSIONS: The number of life-threatening complications and plasma viral load are indicative of the stage of disease progression and may be useful factors for predicting the outcome of HSCT.